Conshohocken, PA, United States of America

Xiaobang Gao


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Keasbey, NJ (US) (2010)
  • Conshohocken, PA (US) (2012)

Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Xiaobang Gao

Introduction

Xiaobang Gao is a notable inventor based in Conshohocken, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical applications. With a total of 2 patents, his work has the potential to impact the treatment of thromboembolic disorders.

Latest Patents

One of Xiaobang Gao's latest patents involves heterocyclic compounds as factor IXA inhibitors. This invention relates to novel heterocyclic compounds of Formulae I-III, as disclosed herein, or a pharmaceutically acceptable salt, solvate, ester, prodrug, or stereoisomer thereof. Additionally, the patent includes pharmaceutical compositions comprising these compounds and methods for using them to treat or prevent thromboembolic disorders.

Career Highlights

Throughout his career, Xiaobang Gao has worked with prominent companies in the pharmaceutical industry, including Schering Corporation and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Xiaobang Gao has collaborated with notable colleagues such as Martin C Clasby and Samuel Chackalamannil. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Xiaobang Gao's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…